Needa A VIRANi

Title: Needa A Virani: Innovator in Gold Nanoparticle Technology

Introduction

Needa A Virani is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of nanotechnology, particularly in the development of gold nanoparticle-ligand conjugates. Her innovative work focuses on targeting tumor cells for enhanced imaging and therapeutic applications.

Latest Patents

Needa A Virani holds a patent for "Gold nanoparticle-ligand conjugates and methods of use." This patent describes a method where gold nanoparticles are conjugated to phosphatidylserine-specific ligands. These conjugates are designed to target and bind to surface-exposed phosphatidylserine on tumor cells and tumor vasculature. The use of these targeted gold nanoparticles significantly increases tumor contrast, allowing for the detection of breast cancer tumors as small as 4 mm via computed tomography (CT) within just 4 hours after injection. This demonstrates the potential of these conjugates as effective imaging agents. Furthermore, the gold nanoparticle conjugates can be utilized for photothermal therapy and can be combined with X-ray radiation treatment for cancer therapy.

Career Highlights

Needa A Virani is affiliated with the University of Oklahoma, where she continues her research and development in nanotechnology. Her work has garnered attention for its innovative approach to cancer treatment and imaging.

Collaborations

Needa collaborates with Roger G Harrison, Jr., contributing to advancements in her field through shared expertise and research efforts.

Conclusion

Needa A Virani's contributions to the field of nanotechnology, particularly through her patented gold nanoparticle-ligand conjugates, highlight her role as an innovator in cancer treatment and imaging. Her work continues to pave the way for advancements in medical technology.